Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
EVAX | US
-0.07
-2.58%
Healthcare
Biotechnology
30/06/2024
18/10/2024
2.64
2.74
2.80
2.64
Evaxion Biotech A/S a clinical-stage biotech company engages in developing artificial intelligence-powered immunotherapies for cancers bacterial diseases and viral infections. The company develops EVX-01 a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02 a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03 a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1 EVX-B2 and EVX-V1 which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm Denmark.
View LessLow Market Beta (-0.4 to 0.8)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
46.2%1 month
55.5%3 months
85.3%6 months
78.0%-
3.57
12.06
8.37
0.69
-0.59
63.35
-
-18.80M
15.58M
15.58M
-
-2.97K
-
-
-802.80
0.90
2.14
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.71
Range1M
0.89
Range3M
1.25
Rel. volume
0.13
Price X volume
23.02K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Kazia Therapeutics Limited | KZIA | Biotechnology | 0.5024 | 16.72M | -4.65% | n/a | 6.82% |
Synlogic Inc | SYBX | Biotechnology | 1.41 | 16.49M | -0.70% | n/a | 0.00% |
LYRA THERAPEUTICS INC | LYRA | Biotechnology | 0.2436 | 15.95M | 4.64% | n/a | 118.63% |
Inhibikase Therapeutics Inc. | IKT | Biotechnology | 2.13 | 15.90M | -9.36% | n/a | 3.49% |
Indaptus Therapeutics Inc. Common Stock | INDP | Biotechnology | 1.5097 | 15.39M | -2.60% | n/a | 2.12% |
ImmunoPrecise Antibodies Ltd | IPA | Biotechnology | 0.54 | 15.13M | 0.19% | n/a | 49.00% |
Cara Therapeutics Inc | CARA | Biotechnology | 0.2651 | 14.97M | -0.64% | n/a | 406.66% |
IMNN | IMNN | Biotechnology | 0.9855 | 14.19M | 0.69% | n/a | 37.13% |
Apollomics Inc. Class A Ordinary Shares | APLM | Biotechnology | 0.1281 | 14.09M | 3.98% | n/a | 21.43% |
Aytu BioScience Inc | AYTU | Biotechnology | 2.29 | 14.08M | 0.00% | n/a | 54.59% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.538 | 7.80M | -6.65% | 0.03 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2201 | 3.95M | 4.26% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.76M | 1.92% | n/a | 17.32% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 897.66K | -12.28% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.38 | 0 | 0.37% | 22.53 | 56.33% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.92 | 0 | -8.84% | n/a | 0.00% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4801 | 0 | -10.26% | n/a | 19.98% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.045 | 0 | -2.34% | n/a | 268.43% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.82 | 0 | 1.93% | 9.09 | 39.79% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.59 | 0.53 | Cheaper |
Ent. to Revenue | 63.35 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 12.06 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 85.26 | 72.80 | Par |
Debt to Equity | 8.37 | -1.23 | Expensive |
Debt to Assets | 0.69 | 0.25 | Expensive |
Market Cap | 15.58M | 3.66B | Emerging |